Ontology highlight
ABSTRACT:
SUBMITTER: Strand V
PROVIDER: S-EPMC6902348 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
Strand Vibeke V Pope Janet J Tundia Namita N Friedman Alan A Camp Heidi S HS Pangan Aileen A Ganguli Arijit A Fuldeore Mahesh M Goldschmidt Debbie D Schiff Michael M
Arthritis research & therapy 20191209 1
<h4>Background</h4>To evaluate the effect of upadacitinib on patient-reported outcomes (PROs) in patients with RA who had an inadequate response to csDMARDs.<h4>Methods</h4>Patients in SELECT-NEXT, a randomised controlled trial, were on a background of csDMARDs and received upadacitinib 15 mg and 30 mg or placebo daily for 12 weeks. PROs included Patient Global Assessment of Disease Activity (PtGA), pain, Health Assessment Questionnaire-Disability Index (HAQ-DI), Functional Assessment of Chronic ...[more]